Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has raised CNY 20 million in a round of funding on August 21, 2023. The transaction included participation from new investors, Anhui Huaheng Biotechnology Co., Ltd. and Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
113.6 CNY | -0.75% | -4.33% | -9.74% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.74% | 2.47B | |
+1.05% | 29.44B | |
+22.05% | 25.23B | |
+6.24% | 11.08B | |
+15.43% | 5.29B | |
+17.59% | 4.43B | |
-7.93% | 3.84B | |
+2.73% | 3.42B | |
-0.32% | 2.97B | |
+25.86% | 2.78B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.